Peter Torp

Relative Adrenal Insufficiency is Associated with the Clinical Outcome in Patients with Stable Decompensated Cirrhosis

Sirtuins as regulators of metabolism and healthspan

Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis

Cardiac dysfunction in patients with cirrhosis

NCoR1 Is a Conserved Physiological Modulator of Muscle Mass and Oxidative Function

LEFT ventricular function assessed by echocardiography in cirrhosis: Relationship to systemic hemodynamics and renal dysfunction

A detailed evaluation of cardiac function in cirrhotic patients and its alteration with or without liver transplantation

Diastolic myocardial dysfunction does not affect survival in patients with cirrhosis

Cirrhotic cardiomyopathy: pathogenesis and clinical relevance

Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance

Systolic dysfunction and diastolic dysfunction do not influence medium-term prognosis in patients with cirrhosis

Thyroid Hormone Regulation of Metabolism

Survival at 2 years among liver cirrhotic patients is influenced by left atrial volume and left ventricular mass

Cardiac and proinflammatory markers predict prognosis in cirrhosis

Systolic and diastolic dysfunction in cirrhosis: a tissue‐Doppler and speckle tracking echocardiography study

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

Assessment of left ventricular ejection fraction may invalidate the reliability of EuroSCORE

Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging